Has Nathan Clements, MD received payments from drug or device companies?

Yes. Drug and device makers reported $29,437 in general payments to Nathan Clements, MD across 305 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nathan Clements, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nathan Clements, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nathan Clements, MD

Interventional Pain Medicine · Saint George, UTNPI 1740716232

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (51.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 66.4% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2021 at $16,665 and has fallen 81.0% since, to $3,172 in 2025. Among interventional pain medicine clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$29,437in general payments, 2019–2025

Across 305 payments — averaging $96.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$20K
Abbott$3K
Medtronic$2K
SPR Therapeutics, Inc$1K
Relievant Medsystems, Inc.$1K
Nevro Corp.$970
plus $1K from 17 others

What the payments were for

Grants$15,00051%
Travel & lodging$4,56215%
Food & beverage$9,87534%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	102	$19,541
Abbott	24	$2,681
Medtronic	50	$2,331
SPR Therapeutics, Inc	17	$1,292
Relievant Medsystems, Inc.	13	$1,136
Nevro Corp.	35	$970
AbbVie	21	$421
MML US, Inc.	2	$176
Si-bone, Inc.	1	$120
Nalu Medical, Inc.	6	$114
Pfizer	6	$113
Lundbeck LLC	5	$84
Protega Pharmaceutials Inc	4	$83
Collegium Pharmaceutical, Inc.	4	$73
Teva Pharmaceuticals USA, Inc.	3	$66
Averitas Pharma Inc.	2	$44
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$42
Vertos Medical, Inc.	2	$36
Bioventus LLC	2	$35
Siemens Medical Solutions USA, Inc.	1	$29
Painteq LLC	1	$25
Biohaven Pharmaceutical Holding Company Ltd.	1	$14
Kowa Pharmaceuticals America, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$29,437 in reported general payments places this provider in the 95th percentile of 26 interventional pain medicine providers in Utah.

See all interventional pain medicine providers in Utah →

Medicare billing

Part B allowed, 2024

$728,285

Medicare patients

848

Services billed

11,263

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	183	$2,947
Pregabalin	80	$1,699
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	64	$1,279
Celecoxib	50	$1,149
Duloxetine Hcl	62	$1,147
Gabapentin	92	$1,094
Cephalexin	53	$419
Oxycodone Hcl	27	$409
Tramadol Hcl	60	$384
Tizanidine Hcl	38	$311
Baclofen	28	$306
Methylprednisolone	34	$233
Cyclobenzaprine Hcl	11	$190
Ropinirole Hcl	15	$136
Meloxicam	16	$65

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Saint George

Steven LarsenSaint George$14K
Bryan HoelzerVineyard$718K
Rick ObraySt George$23K
Brian RichardsonLogan$19K
Alex NelsonMurray$17K
J Riley StringhamProvo$13K
Craig DavisWest Jordan$13K
Geeta NagpalWest Jordan$11K
Ashleigh ByrneWest Jordan$11K
Jie LuoSalt Lake City$8K

See the full list for Utah →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →